Plaintiffs seek class certification in US Xyrem pay-for-delay suit
MLex Summary: Plaintiffs accusing Jazz Pharmaceuticals, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Par Pharmaceuticals and Lupin Pharmaceuticals of conspiring to delay a generic entry of Xyrem asked a US federal judge to certify a...To view the full article, register now.
Already a subscriber? Click here to view full article